In vivo detection of short- and long-term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain

Synapse

Volumn 29, Issue 2, 1998, Pages 183-192

  Scheffel, Ursula ^a,b   Szabo, Zsolt ^a   Mathews, William B ^a   Finley, Paige A ^a   Dannals, Robert F ^a   Ravert, Hayden T ^a   Szabo, Katalina ^a   Yuan, Jie ^a   Ricaurte, George A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

11C (+)McN5652; 11C ( )McN5652; 11C RTI 55 ( 11C CIT); MDMA (3,4 methylenedioxymethamphetamine); Neurotoxicity; Papio anubis; PET (positron emission tomography) imaging; Serotonin (5 HT)

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBON 11; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; BRAIN REGION; CONTROLLED STUDY; HYPOTHALAMUS; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; NEOCORTEX; NEUROTOXICITY; NONHUMAN; OCCIPITAL CORTEX; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; CARBON ISOTOPES; CARRIER PROTEINS; COCAINE; IODINE RADIOISOTOPES; ISOQUINOLINES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; PAPIO; RADIOLIGAND ASSAY; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031945694     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.0.CO;2-3     Document Type: Article

References (46)

1. Battaglia, G., Yeh, S.Y., O'Hearn, E., Molliver, M.E., Kuhar, M.J., and deSouza, E.B. (1987) 3,4 Methylenedioxymethamphetamine and 3,4 methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of 3H-paroxetine labeled serotonin uptake sites. J. Pharmacol. Exp. Ther., 242:911-916.
2. Battaglia, G., Sharkey, J., Kuhar, M.J., and DeSouza, E.B. (1991) Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylene dioxymethamphetamine): Assessment using quantitative autoradiography. Synapse, 8:249-260.
3. 125I]5-iodo-6-nitroquipazine: A potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats. Brain Res., 619:236-246.
4. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse, 12:27-36.
5. 123I]β-CIT. Binding kinetics in the human brain. J. Neural Transm., 94:137-146.
6. 123I]3β-(4-iodophenyl)tropane-2β-carboxilic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporter in vivo. Med. Chem. Res., 1:969-981.
7. 125I]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse, 12:37-46.
8. Commins, D.L., Vosmer, G., Viris, R., Woolverton, W., Schuster, C., and Seiden, L.S. (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in rat brain. J. Pharmacol. Exp. Ther., 241:338-345.
9. 11C]WIN-35,428). J. Label. Compounds Radiopharm., 33:147-152.
10. Dannals, R.F., Scheffel, U., Suehiro, M., and Ricaurte, G.A. (1994) Radioligand development for studying serotonin uptake sites with positron emission tomography. Med. Chem. Res., 5:228-244.
11. 3H]citalopram contrasted to labeling multiple sites by [3H]imipramine. J. Pharmacol. Exp. Ther., 242:364-371.
12. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse, 16:93-103.
13. Fischer, C.A., Hatzidimitriou, G., Katz, J.L., and Ricaurte, G.A. (1995) Reorganization of ascending serotonin axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine. J. Neurosci., 15:5476-5485.
14. Green, A.R., Cross, A.J., and Goodwin, G.M. (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology, 119:247-260.
15. 3H]paroxetine binding in rat cortical membranes. Eur. J. Pharmacol., 118:107-114.
16. Innis, R.J., Baldwin, R.R., Sybirska, E., Zea, Y., Laruelle, M., Al-Tikriti, M., Charney, D., Zoghbi, S., Smith, E., Wisniewski, G., Hoffer, P., Wang, S., Milius, R., and Neumeyer, J. (1991) Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. Eur. J. Pharmacol., 200:369-370.
17. Insel, T.R., Battaglia, G., Johannson, J., Marra, S., and DeSouza, E.B. (1989) 3,4-Methylenedioxymethamphetamine ("Ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J. Pharmacol. Exp. Ther., 249:713-720.
18. 123I]5-iodo-6-nitroquipazine. Eur. J. Pharmacol., 242:189-1993.
19. Jagust, W.J., Eberling, J.L., Biegon, A., Taylor, S.E., VanBrocklin, H.F., Jordan, S., Hanrahan, S.M., Roberts, J.A., Brennan, K.M., and Mathis, C.A. (1996) Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J. Nucl. Med., 37:1207-1214.
20. 125I]RTI-55. Synapse, 12:99-111.
21. Kuikka, J.T., Bergstrom, K.A., Ahonen, A., Hiltunen, J., Kaukka, J., Lansimies, E., Wang, S., and Neumeyer, J.L. (1995) Comparison of iodine-123-labelled carbomethoxy-3-β-(4-iodophenyl) tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur. J. Nucl. Med., 22:356-360.
22. Laihinen, A.O., Rinne, J.O., Nagren, K.A., Lehikoinen, P.K., Oikonen, V.J., Ruotsalainen, U.H., Ruottinen, H.M., Rinne, U.K. (1995) PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease. J. Nucl. Med., 36:1263-1267.
23. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse, 13:295-309.
24. 123I]-β-CIT binding to dopamine transporters in healthy human subjects. J. Cereb. Blood Flow Metab., 14:982-994.
25. Lidow, M., and Goldman-Rakic, P. (1989) Quantitative autoradiographic mapping of serotonin 5-HT1 and 5-HT2 receptors and uptake sites in the neocortex of the rhesus monkey. J. Comp. Neurol., 280:27-42.
26. Maryanoff, B.E., McComsey, D.F., Gardocki, J.F., Shank, R.P., Costanzo, M.J., Nortey, S.O., Schneider, C.R., and Setler, P.E. (1987) Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships. J. Med. Chem., 30:1433-1454.
27. 125I]5-Iodo-6-nitro-2-piperazinylquinoline: A potent and selective ligand for the serotonin uptake complex. Eur. J. Pharm., 210:103-104.
28. 125I]5-Iodo-6-nitroquipazine: A potent and selective ligand for the 5-hydroxytrypt-amine uptake complex. I. In vitro studies. Brain Res., 619:229-235
29. 11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl. Med. Biol., 20:249-255.
30. Ricaurte, G.A., Delanney, L.E., Irwin, I., and Langston, J.E. (1988a) Toxic effects of 3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in the primate: Importance of route and frequency of drug administration. Brain Res., 446:165-168.
31. Ricaurte, G.A., Delanney, L.E., Wiener, S.G., Irwin, I., and Langston, J.W. (1988b) 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of nonhuman primates. Brain Res., 474:359-363.
32. Ricaurte, G.A., Forno, L.S., Wilson, M.A., DeLanney, L.E., Irwin, I., Molliver, M.E., and Langston, J.W. (1988c) (±)3,4 Methylenedioxymethamphetamine (MDMA) selectively damages central serotonergic neurons in nonhuman primates. JAMA, 260:51-55.
33. Ricaurte, G.A., Martello, A.L., Katz, J.L., and Martello, M.B. (1992) Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observation. J. Pharmacol. Exp. Ther., 261:616-622.
34. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse, 11:134-139.
35. Scheffel, U., Dannals, R.F., Suehiro, M., Ricaurte, G.A., Carroll, F.I., Kuhar, M.J., and Wagner, H.N. Jr. (1994a) Development of PET/ SPECT ligands for the serotonin transporter. In: NIDA monograph #138: Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. H. Sorer and R.S. Rapaka, eds., pp. 111-130.
36. 125I]RTI-55. Synapse, 16:263-268.
37. Scheffel, U., Szabo, Z., Matthew, W.B., Finley, P.A., Dannals, R.F., Ravert, H.T., Szabo, K., and Ricaurte, G.A. (1995) In vivo detection of MDMA neurotoxicity in vivo. PET studies in the living baboon brain (Abstract). Society for Neuroscience, San Diego, CA.
38. Schmidt, C.J. (1986) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther., 240: 1-7.
39. Shank, R.P., Vaught, J.L., Pelley, K.A., Setler, P.E., McComsey, D.F., and Marynoff, B.E. (1988) McN-5652: A highly potent inhibitor of serotonin uptake. J. Pharm. Exp. Ther., 247:1032-1038.
40. 125I]RTI-55: In vitro binding and autoradiographic characterization. J. Neurochem., 62:549-556.
41. Stone, D.M., Merchant, K.M., Hanson, G.R., and Gibb, J.W. (1987) Immediate and long term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology, 26:1677-1783.
42. 11C]McN-5652-Z. J. Lab. Comp. Radiopharm., 31:841-848.
43. Suehiro, M., Scheffel, U., Dannals, R.F., Ravert, H.T., Ricaurte, G.A., and Wagner, H.N. Jr. (1993a) A PET radiotracer for studying serotonin uptake sites: Carbon-11-McN-5652Z. J. Nucl. Med., 34:120-127.
44. 11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Life Sci., 53:883-892.
45. 11C]McN5652. J. Cereb. Blood Flow Metab., 15:798-805.
46. 11C](+)McN5652. Synapse, 20:37-43.